Peter Lin MD, CCFP
Director, Primary Care Initiatives, Canadian Heart Research Centre, North York, OntarioDr. Peter Lin, a primary care physician, is the Director of Primary Care Initiatives at the Canadian Heart Research Centre and has two busy family medicine practices in Toronto. For 7 years, he served as the medical director at the University of Toronto Scarborough Health & Wellness Centre. In 2011, he received a teaching award from the College of Family Physicians of Canada.
Dr. Lin has worked with KDIGO (Kidney Disease│Improving Global Outcomes) in an effort to help enhance care for patients with chronic kidney disease. He has been a contributing author to the Canadian Diabetes Guidelines and has served on the editorial board of Pri-Med Institute, which provides education for physicians.
Dr. Lin maintains an active lecture schedule, reflecting his varied medical interests, continuing his focus on bridging the chasm between research and clinical practice.
Disclosures
- Consultant (continuing medical education programs): AstraZeneca; Boehringer Ingelheim; Bayer; Eli Lilly; Amgen; Janssen; Merck; Pfizer; Sanofi; Abbott; HLS Therapeutics
Recent Contributions to PracticeUpdate:
- The Metabolic Syndrome and Risk of Sudden Cardiac Death
- Metabolically Healthy Obese People and Incident Cardiovascular Disease Events
- Optimizing Cholesterol Treatment in Patients With Muscle Complaints
- Position Statement by the ADA: Diabetes and Hypertension
- ESC 2017 Guidelines and Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease
- Rivaroxaban With or Without Aspirin in Stable Cardiovascular Disease
- Effect of Multifactorial Treatment Targets and Relative Importance of HbA1c, Blood Pressure, and LDL Cholesterol on Cardiovascular Diseases in Patients With Type 2 Diabetes
- Effect of Intensive vs Standard Blood Pressure Treatment According to Baseline Prediabetes Status
- Metformin for Diabetes Prevention
- Treatment of Cholesterol in 2017